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Abstract. The aggregation states of the epidermal 
growth factor receptor (EGFR) on single A431 human 
epidermoid carcinoma cells were assessed with two new 
techniques for determining fluorescence resonance en- 
ergy transfer: donor photobleaching fluorescence reso- 
nance energy transfer (pbFRET) microscopy and fluo- 
rescence lifetime imaging microscopy (FLIM). 
Fluorescein-(donor) and rhodamine-(acceptor) la- 
beled EGF were bound to the cells and the extent of 
oligomerization was monitored by the spatially re- 
solved FRET efficiency as a function of the donor/ 
acceptor ratio and treatment conditions. An average 
FRET efficiency of 5 % was determined after a low 
temperature (4°C) incubation with the fluorescent 
EGF analogs for 40 min. A subsequent elevation of the 
temperature for 5 min caused a substantial increase of 
the average FRET efficiency  to 14% at 20°C and 31% 
at 37°C. In the context of a two-state (monomer/dimer) 
model for the EGFR, these FRET efficiencies were 
consistent with minimal average receptor dimerizations 
of 13, 36, and 69% at 4, 20, and 37°C, respectively. 
A431 cells were pretreated with the monoclonal anti- 
body mAb 2E9 that specifically blocks EGF binding to 
the predominant population of low affinity  EGFR (15). 
The average FRET efficiency  increased dramatically  to 
28% at 4°C, indicative of a minimal receptor dimeriza- 
tion of 65% for the subpopulation of high affinity re- 
ceptors. These results are in accordance with prior stud- 
ies indicating that binding of EGF leads to a fast and 
temperature-dependent microclustering of EGFR, but 
suggest in addition that the high affinity functional sub- 
class of receptors on quiescent A431 cells are present in 
a predimerized or oligomerized state. We propose that 
the transmission of the external ligand-binding signal to 
the cytoplasmic domain is effected by a concerted rela- 
tive rotational rearrangement of the monomeric units 
comprising the dimeric receptor, thereby potentiating a 
mutual activation of the tyrosine kinase domains. 
PIDERMAL growth factor (EGF)  1 is a mitogen of 53 
amino acids that stimulates the proliferation and 
differentiation of numerous cell types, particularly 
of epithelial lineage (for reviews  see 6, 7, 50). The EGF 
receptor  (EGFR)  is  a  single  polypeptide  chain  (1186 
amino acids) of 170 kD that spans the membrane once via 
an a-helical segment of 23 hydrophobic amino acids. The 
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extracellular domain (621 amino acids)  is heavily glyco- 
sylated (contributing 40 kD to the molecular mass)  and 
contains the EGF-binding site. The intracellular domain 
(542 amino acids) is the locus of a latent tyrosine kinase, 
the ligand-dependent activation of which  leads to auto- 
phosphorylation and phosphorylation of exogenous sub- 
strates. The growth factor tyrosine kinase receptor (TKR) 
activates.many proteins  directly  or  indirectly,  thereby 
modulating their effector function in signal transduction 
(for reviews see references 5, 43, 50). Some examples  are 
phospholipase  C-~11 (PLC-~/1),  phosphatidylinositol-Y- 
kinase (PI3-kinase), and the ras GTPase-activating protein 
(ras  GAP).  These  signal  transduction proteins  interact 
physically with the autophosphorylated receptor via SH2 
domains (second domain of src homology) conferring high 
specificity and affinity (44), and leading to the formation 
of multicomponent signal transduction complexes. A link- 
age has been recently demonstrated between the activa- 
tion of EGFR and that of the oncogenic GTP-binding pro- 
tein Ras (for review see reference 41), mediated via two 
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ing protein) and guanine nucleotide-releasing factor Sos. 
Grb2 bridges activated TKR and Sos, leading to a translo- 
cation of the latter to the plasma membrane where it in- 
duces the exchange of GDP for GTP on Ras. GTP-Ras 
binds to RAF-l-kinase, thereby initiating the MAP-kinase 
cascade  resulting in the  direct phosphorylation of tran- 
scription factors and ultimately eliciting the primary mito- 
genic response, stimulation of DNA replication, and cell 
division (34, 36). 
The regulation by EGF of cellular proliferation consti- 
tutes  the  first  signal transduction  pathway that  can  be 
traced from the plasma membrane to the nucleus without 
obvious gaps in the mechanism. However, the initial steps 
in EGFR activation (for reviews see references 40, 43, 50) 
remain controversial. Two models have been  proposed. 
The  first stipulates that  external binding of the  growth 
hormone  stimulates  the  tyrosine  kinase  activity in  the 
cytoplasmic  domain  via  an  unspecified  conformational 
change  transmitted through  the  single  membrane-span- 
ning region. Two observations support this hypothesis. A 
single mutation of one amino acid in the membrane-span- 
ning segment of the receptor yields a  constitutively acti- 
vated receptor (tyrosine kinase) uncoupled to EGF bind- 
ing (48). Secondly, immobilization of purified receptor on 
affinity columns or dilution in detergent solution also lead 
to  activation of the tyrosine kinase  (6).  The alternative 
more generally accepted model, denoted allosteric recep- 
tor oligomerization (56, 57) (for reviews see references 40, 
50),  invokes an intermolecular mechanism in which EGF 
binding promotes receptor dimerization, the consequences 
of which are enhanced affinity for the growth factor and 
activation of the TKR. Evidence for this model derives 
from several independent observations: electron micros- 
copy of immunogold-labeled receptors shows gold particle 
clustering upon administration of EGF (51); divalent anti- 
bodies  directly activate  the  receptor  in  the  absence  of 
EGF (46);  the activation kinetics using solubilized recep- 
tors have a second order dependence on receptor concen- 
tration (57); and chemical cross-linking studies confirm the 
occurrence of EGF-induced (13,  18)  or covalently stabi- 
lized (45) receptor dimerization. 
Most of the studies of the EGFR have been performed 
on A431 cells or membranes derived thereof. A431 is an 
established  human  epidermoid  cancer  cell  line  overex- 
pressing cell surface EGFR to a level of up to 2 ×  106 re- 
ceptors/cell and secreting large quantities of the extracel- 
lular domain (16, 49). In this and other cell lines (59) two 
populations of receptors are present with different affini- 
ties for EGF: low affinity EGFR (Kd >  1 nM) and high af- 
finity EGFR (Kd <  1 nM). In A431 cells, the high affinity 
receptors comprise N2-12%  of the total (14,  19, 37, 59). 
Defize and colleagues have described a monoclonal anti- 
body, mAb 2E9, that specifically blocks EGF binding to 
the low affinity sites (15). EGF-dependent signal transduc- 
tion is retained in cells exposed to mAb-2E9, suggesting 
that the high affinity-receptor population (2-12%) is nec- 
essary and sufficient for EGF function (15). The combined 
observations that dimerization of the EGFR parallels re- 
ceptor (tyrosine kinase) activation (3, 46, 56, 57), that re- 
ceptor dimerization increases the affinity for EGF (3, 56, 
57),  and that signal transduction can be effected via the 
high affinity receptors  alone  (2,  15,  57)  dearly demon- 
strate a  correlation between binding to the high affinity 
EGFR, receptor dimerization, and receptor activation. It 
has been proposed that the high affinity receptor is associ- 
ated preferentially with the cytoskeleton (37, 52, 53, 59), 
suggesting  an  essential  role  of the  cytoskeleton in  the 
transmission of the signal (24). 
Despite the mass of experimental evidence, the infer- 
ence that ligand-induced dimerization is a prerequisite for 
tyrosine kinase activation has been questioned repeatedly 
(10), particularly in view of the fact that most studies per- 
formed  with  the  overexpressing  A431  cells  have  dealt 
with the total EGFR population, most members of which 
are  of the  nonfunctional low affinity class.  In  addition, 
many of the investigations have dealt with EGFR in mem- 
brane fragments, in detergent-stabilized extracts, or recon- 
stituted into lipid bilayers. None of these conditions can be 
presumed to mimic the native cellular environment in its 
entirety. 
We have studied the phenomenon of receptor oligomer- 
ization using newly developed techniques based  on the 
quantitative determination of fluorescence resonance en- 
ergy transfer (FRET) in the microscope, i.e., with reten- 
tion of spatial resolution. The basis of FRET is the transfer 
of excited state energy from a donor fluorescent group to 
an  appropriate  light  absorbing  acceptor  molecule. This 
process takes place only over very short distances (gener- 
ally <10 nm) with an efficiency dependent upon the in- 
verse 6th power of the donor-acceptor separation. Thus, 
FRET is a sensitive and direct measure of very close mo- 
lecular interactions. FRET is manifested in different ways: 
a  decreased  donor  fluorescence  quantum  yield,  a  de- 
creased donor fluorescence lifetime, and an increased sta- 
bility of the donor towards chemical photobleaching (for 
references see 28-30). We employed luminescent probes 
covalently linked to the single terminal amino group of 
EGF as donor and acceptor molecules. Such extrinsic fluo- 
rescent groups, as well as extrinsic protein fluorescence, 
have been used previously in other studies of the distribu- 
tion, growth factor binding, internalization, and mecha- 
nism of activation of EGFR on living cells or in isolated 
plasma membranes (9, 23, 26, 27, 42, 59--61). In particular, 
FRET has been applied in a study of EGFR aggregation 
on A431  cells and plasma membrane preparations  with 
fluorescent EGF derivatives as donor-acceptor pairs (1, 8, 
11). These measurements were based on donor quenching 
and sensitized acceptor emission for monitoring receptor 
clustering. Here, we describe experiments on receptor oli- 
gomerization using much more sensitive and accurate de- 
terminations  of FRET  based  on  donor-photobleaching 
(pbFRET)  digital imaging microscopy (28-30)  and fluo- 
rescence  lifetime imaging microscopy (FLIM)  (12,  21). 
The increased sensitivity and accuracy of these methods 
are due to the application of very sensitive detection de- 
vices such as slow-scan CCD-cameras and an image inten- 
sifier (FLIM) to high illumination levels combined with 
long integration times (pbFRET), and the exploitation of 
temporal phenomena rather than relative fluorescence in- 
tensities.  Another  major  virtue  of this  approach,  com- 
pared to the use of cells in suspension, is the retention of 
information  related  to  the  spatial  distribution  of  the 
EGFR. The data confirm that a process of EGF-induced 
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alized on single cells, but the evidence suggests that the 
high affinity receptor subpopulation is present in an oligo- 
merized state in intact cells, even in the absence of the 
growth factor ligand. A model is presented in which such 
preexistent  homodimeric complexes  are  activated by a 
simple, i.e., nonallosteric, ligand-induced reorientati0n of 
the two partners comprising the EGFR dimer. This pro- 
cess is presumed to be transmitted by concerted rotational 
motions of the transmembrane and cytoplasmic domains, 
such  that  the  tyrosine  kinase  domains  achieve  a  ste- 
reochemical  configuration leading to  mutual  activation. 
This mode of stereochemical activation provides an alter- 
native to the mechanism of allosteric receptor oligomer- 
ization generally attributed to the large family of growth 
factor receptors. 
Materials and Methods 
Reagents 
Fluorescein-EGF (F1-EGF) and tetramethyl-rhodamine-EGF (Rh-EGF) 
were prepared from native-EGF by labeling with FITC and TRITC, re- 
spectively, and were purified as described elsewhere (1, 59). Concentra- 
tions of native-, Fl-, and Rh-EGF were determined by using molar extinc- 
tion coefficients E280 ~  18,700 M -1 cm  -1, 6493  =  73,000 M -1 cm  -1 and ~555 
=  83,000 M -1 cm  -1, respectively (1, 59). The rnAb 2E9 was a  kind gift 
from Dr. Defize (Hubrecht Laboratory Utrecht, The Netherlands). Cell 
culture reagents were from Cellgro  (Herndon, VA) and GIBCO  BRL 
(Gaithersburg, MD).  Solvents for spectroscopic measurements were  of 
spectroscopic grade, and other chemicals were of analytical grade. 
Cells and Culture Conditions 
A431 human epidermoid carcinoma cells were grown in a 5% COz humid- 
ified atmosphere at 37°C in DMEM supplemented with 10% FBS, 1 mM 
sodium pyruvate, 10 mM NaHCO3, 10 mM N-tris[hydroxymethyl]meth- 
yl-2-aminoethane-sulfonic acid,  10  mM  Hepes,  10  mM  N,N-bis[2-hy- 
droxyethyl]-2-aminoethane sulfonic acid, pH 7.3, 104 U/L penicillin G 
and 100 mg/L streptomycin sulfate. After splitting the cells, 2 ×  105 cells 
were added per petri dish containing medium and seven glass coverslips 
(20 mm diameter; ~8,000 cells per coverslip). The coverslips were used af- 
ter 2-3 d. 
Labeling Procedures 
Coverslips were  transferred  to  humid incubation chambers (h×w×l  = 
1×10×15 cm) cooled on ice and washed three times with ice cold PBS. 
Native-, FI-, and Rh-EGF were added in various ratios at a total EGF con- 
centration of 50 nM in ice cold PBS supplemented with 50 mM glucose, 5 
mM MgC12, 8.7 mM CaC12 and 1% (wt/vol) BSA. In the experiments on 
the high affinity EGF receptors, the ceils were preincubated with a nine- 
fold diluted solution of the monoclonal antibody 2E9 (mAb 2E9) (300 nM) 
in the PBS buffer described above for 4 h at 4°C. After three washes with 
ice cold PBS, the cells were incubated with EGF as described above. The 
EGF incubations were carried out for 40 min at 4°C and subsequently at 
various temperatures and for various times according to the experimental 
protocol. The coverslips were then washed three times with ice cold PBS 
and fixed with ice cold 4% (wt/vol) paraformaldehyde in PBS for 5 rain, 
after which the fixation was continued at room temperature for an addi- 
tional 15 min. Cells were washed twice with PBS, once with a buffer con- 
taining 50 mM Tris HC1, pH 7.4, 100 mM NaC1, and mounted in the same 
buffer on microscope slides within a ring of nail polish to prevent squash- 
ing the cells. The preparations were used directly for microscopy after air 
tight sealing with nail polish. 
pbFRET Fluorescence Microscopy 
A Zeiss Axioplan microscope equipped with epi-lllumination and fluores- 
cence detection optics was used. The excitation source was an HBO 100 
W mercury lamp (Osram, Germany). All images presented here were oh- 
tained with a  Zeiss Plan-Neofluar 40x  NA 1.4 oil immersion objective. 
Imaging of fluorescein emission (FI-EGF) was with the filter combination: 
Zeiss 450--490 nm, excitation; Omega FT 500, dichroic (Omega Optical, 
Inc. Brattleboro, VT); and Omega 525 DF 30, emission. For collecting the 
rhodamine fluorescence (Rh-EGF), the filters were: Zeiss BP 546, excita- 
tion; Zeiss FT 580, dichroic; and Zeiss LP 590, emission. Image acquisition 
was with a  slow-scan Series 200  (CH220)  CCD camera (Photometrics, 
Tucson, AZ). The camera had a thermoelectrically cooled Kodak KAF- 
1400 CCD sensor with 1320×1035 (available) 6.8-~m pixels coated with 
the Metachrome-II down converter. The system was interfaced to an Ap- 
ple Macintosh Ilfx computer via a Photometrics NU200 controller. 
The specimens were illuminated constantly and a sequence of fluores- 
cence micrographs (usually 31, each 7.5-10 s in duration) was acquired 
with the CCD camera. Successive micrographs (subimages) exhibited de- 
creasing intensities with time due to the photobleaehing process. After ex- 
porting the data to a DEC MicroVax II computer, a pixel-by-pixel single 
exponential decay (DECAY program, (30); Gadella, T. W. Jr., and T. M. 
Jovin, manuscript in preparation) was fit to the sequence of subimages, 
thereby providing images of the photobleaching amplitudes and time con- 
stants, the residual background intensities and other information. The 
FRET efficiency E  (range 0-1) was calculated from the photobleaching 
time constants of the FRET-donor obtained in the absence (%1) or pres- 
ence (x'bl) of the FRET-acceptors according to 
"~bl 
E  =  1---  (1) 
'l'~bl 
In a two state model accounting for only two populations of receptors, ei- 
ther in a monomeric or in a dimeric state, it can be shown that the minimal 
amount of receptor dimerization (txmt.) is related to E and the fraction of 
acceptor labeled EGF (relative to the total amount of added EGF) fA ac- 
cording to Eq. 2 (see also Appendix). 
8E 
°tmin  fA (2 +  E) 2  (2) 
Fluorescence Lifetime Imaging Microscopy 
The frequency domain fluorescence lifetime imaging microscope has been 
described in detail (12, 21). Briefly, the microscope consisted of an epi- 
illumination Zeiss Universal Microscope (Oberkochen, FRO), coupled to 
an image intensifier-CCD detection system. The excitation source was the 
488-nm line of an argon-ion laser modulated with acousto-optical modula- 
tors. After passing through a quartz optical fiber (0.2 mm diameter, sev- 
eral meters in length), the central (zero order)  diffraction spot was di- 
rected into the side port of the microscope epi-illuminator. The image 
intensifier (PCO Computer Optics GmbH, Kelheim, FRG), consisted of a 
microchannel-plate (MCP) intensifier, a $20 photocathode gateable down 
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Figure 1.  Competitive binding of native-, Rh-, and F1-EGF. A431 
cells were incubated with 50 nM EGF (total concentration) as de- 
scribed  with  various  ratios  of F1-EGF/native-EGF  (©)  or  Rh- 
EGF/native-EGF  (O). After labeling for 40 min at 4°C, the cells 
were fixed and used for microscopy as described. The relative av- 
erage fluorescence intensity from three representative groups of 
cells is plotted against the labeling ratio. 
Gadella and Jovin Model for Tyrosine Kinase Receptor Aetivation  1545 ~
V
 
o
_
 
U
,
 
4
:
-
 
O
~
 
F
i
g
u
r
e
2
.
 
P
h
o
t
o
b
l
e
a
c
h
i
n
g
 
F
R
E
T
 
m
i
c
r
o
s
c
o
p
y
 
o
f
 
F
I
-
E
G
F
 
b
o
u
n
d
 
t
o
 
A
4
3
1
 
c
e
l
l
s
 
w
e
r
e
 
l
a
b
e
l
e
d
 
w
i
t
h
 
1
6
.
7
 
n
M
 
F
I
-
E
G
F
 
a
n
d
 
3
3
.
3
 
n
M
 
n
a
t
i
v
e
 
E
G
F
 
a
t
 
4
°
C
 
f
o
r
 
4
0
 
m
i
n
 
a
n
d
 
t
h
e
n
 
f
o
r
 
5
 
r
a
i
n
 
a
t
 
2
0
°
C
.
 
T
h
e
 
c
e
l
l
s
 
w
e
r
e
 
t
h
e
n
 
f
i
x
e
d
 
a
n
d
 
m
o
u
n
t
e
d
 
a
s
 
d
e
s
c
r
i
b
e
d
.
 
A
 
s
e
q
u
e
n
c
e
 
o
f
 
3
1
 
f
l
u
o
r
e
s
c
e
n
c
e
 
m
i
c
r
o
g
r
a
p
h
s
 
c
o
m
b
i
n
e
d
 
t
o
g
e
t
h
e
r
 
i
n
 
o
n
e
 
i
m
a
g
e
 
w
a
s
 
t
a
k
e
n
 
w
i
t
h
 
t
h
e
 
C
C
D
 
c
a
m
e
r
a
.
 
T
h
e
 
f
i
r
s
t
 
(
a
 
d
a
r
k
 
i
m
a
g
e
)
 
w
a
s
 
a
c
q
u
i
r
e
d
 
w
i
t
h
 
t
h
e
 
e
x
c
i
t
a
t
i
o
n
 
s
h
u
t
t
e
r
 
c
l
o
s
e
d
 
a
n
d
 
t
h
e
 
o
t
h
e
r
s
 
b
y
 
o
p
e
n
i
n
g
 
t
h
e
 
s
h
u
t
t
e
r
 
f
o
r
 
7
.
5
 
s
.
 
T
h
e
 
d
i
g
i
t
a
l
 
i
m
a
g
e
 
s
e
q
u
e
n
c
e
 
w
a
s
 
t
r
a
n
s
f
e
r
r
e
d
 
t
o
 
t
h
e
 
D
E
C
 
M
i
c
r
o
 
V
a
x
 
I
I
 
a
n
d
 
a
n
a
l
y
z
e
d
 
w
i
t
h
 
t
h
e
 
D
E
C
A
Y
 
p
r
o
g
r
a
m
.
 
T
h
e
 
g
e
n
e
r
a
t
e
d
 
o
u
t
p
u
t
 
w
a
s
 
i
m
a
g
e
 
p
r
o
c
e
s
s
e
d
 
b
y
 
u
s
e
 
o
f
 
a
 
T
C
L
-
I
m
a
g
e
 
m
a
c
r
o
 
y
i
e
l
d
i
n
g
 
t
h
e
 
f
i
n
a
l
 
d
i
s
p
l
a
y
e
d
 
i
m
a
g
e
.
 
F
o
r
 
f
u
r
t
h
e
r
 
d
e
t
a
i
l
s
 
s
e
e
 
M
a
t
e
r
i
a
l
s
 
a
n
d
 
M
e
t
h
o
d
s
.
 Figure 3.  pb-FRET microscopy of FI-EGF and Rh-EGF bound to A431 cells after a 5-rain exposure to 37°C. A431 cells were labeled 
with 16.7 nM F1-EGF and either 33.3 nM native-EGF (top images) or 33.3 nM Rh-EGF (bottom images) at 4°C for 40 rain and then for 
5 min at 37°C. The cells were then fixed and mounted as described. Two sequences (one per labeling condition) of 21 fluorescence mi- 
crographs were acquired by the CCD camera, using a shutter open time of 11 s. Corresponding phase contrast images were also taken. 
The digital sequence images were transferred to the DEC MicroVax II and merged together in one sequence by use of a macro written 
in TCL-Image. This sequence image was analyzed as in Fig. 2. The standard output of the DECAY program was modified with TCL- 
Image in order to generate a more compact output comprised of: phase contrast images of the cells (top left), the initial fluorescence im- 
ages (bottom left), the Tbl images (top middle), the Tbl temporal histogram (bottom middle), and the two-dimensional  "rbl vs Ampl. histo- 
gram (top right). For the average image statistics (Table I), the two sequences were also analyzed separately. 
to ~5 nsec, a P46 phosphor, and provision for a high frequency (HF) mod- 
ulation input directly at the high voltage MCP stage. The HF driving cur- 
rent was provided by a power amplifier driven at a frequency 40 Hz (= Af) 
higher than that of the AOMs. The CCD camera system (Photometries 
Series 200, Tucson, AZ) incorporated a mechanical shutter and a thermo- 
electrically  cooled  CSF-Thomson  7882(1)A  CCD  sensor of  576×384 
23×23 v.m square pixels with a Metachrome II down converter coating to 
boost the blue sensitivity. The camera controller was interfaced to an Ap- 
ple Macintosh  Ilci computer and operated with a dedicated acquisition 
program implemented with LabView (National Instr., Austin, TX). 
The donor (fluorescein) fluorescence was collected with a Zeiss FI" 505 
dichroic mirror and a Zeiss PB 520-540-nm emission filter. The sequence 
of phase images was acquired  using the heterodyne "boxcar" mode of 
measurement (20, 21). One phase image was obtained by applying a gate 
of 4 ms to the cathode of the MCP intensifier at one particular phase set- 
ting of the low frequency (Af) signal, and integration of the ensuing signal 
on the phosphor screen of the MCP intensifier for 2 s on the CCD. Twenty 
images were recorded by gating the fluorescence  signal at time delays 
varying from 0--18 ms within the 40 Hz heterodyne cycle. The first 10 im- 
ages were obtained by increasing the time delay with steps of 2 ms and the 
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Photobleaching Experiments 
Temperature  Acceptor* 
°C  yes/no  %1  E~:  CV§  s.e.I  N~ 
s  %  %  s 
4  no  39.8  -  6  1.2  6998 
4  yes  41.7  4.6  4  1.5  7311 
20  no  40.3  -  4  0.9  6195 
20  yes  46.8  14  3  1.0  3701 
37  no  30.6  -  5  1.7  21687 
37  yes  44.1  31  5  1.6  20513 
4  no  39.6  -  6  1.7  7920 
4  yes  41.4  4.3  4  1.7  7920 
4**  no  43.2  -  6  2.7  7920 
4**  yes  60.2  28  12  4.6  7920 
* Presence/absence of acceptor. No, incubation with FI-EGF/native-EGF =  1:2; Yes, 
incubation with F1-EGF/Rh-EGF  =  1:2. 
~: Effective average energy transfer calculated from Eq. 1. 
§ Coefficient of variation in %1 (100 × SD/mean,  all pixels). 
I Average standard error per individual  %~ determination. 
Number of analyzed pixels (single exponentials), in all cases the average correlation 
coefficients were ~99.2% and the average residuals (= ~[observed - calculated]2/ 
~observed:) were ~5%. 
** With added 2E9 monoclonal antibody. 
last 10 by decreasing the time delay in 2 ms steps. By addition of the digi- 
tized intensities of the images with equal time delay, photobleaching ef- 
fects (up to a  maximal 20%) were corrected (21). The phase shift (A~) 
and modulation (M) were determined at every pixel from the series of images 
relative to that of scattered excitation light using the fit program SINUS 
(20). The  overall fluorescence lifetimes ('r~ and "rM) were calculated ac- 
cording to Eqs. 3 and 4 using 2~r'39.19"106 s -1 as the radial frequency to. 
"r~,  =  ltan  (A~P)  (3) 
"I'M  -----  ~  --  1  (4) 
Results 
Relative Affinities of  Fl-, Rh-, and Native-EGF 
The relative  affinities of F1-  and Rh-EGF compared to 
that of native-EGF were investigated by studying the fluo- 
rescence  intensity  of the  labeled  compounds  bound  to 
A431 cells upon dilution with native-EGF (Fig. 1). As can 
be inferred from the very linear relationships of relative 
fluorescence intensity and the fractional contribution of 
labeled EGF added to the A431 cells, the affinities of F1- 
and Rh-EGF were very similar to that of native EGF. A 
similar conclusion was reached by others (1, 8). 
pbFRET Microscopy of  FI-EGF 
A  typical donor photobleaching  experiment  of F1-EGF 
bound to A431 cells is shown in Fig. 2. The figure is a com- 
posite  graphical  output  produced  by  the  fit  program 
DECAY  and  image-processing  in  TCL-Image  as  de- 
scribed in Gadella, T. M. Jr., and T. M. Jovin (manuscript 
in preparation).  The first  row of subimages  depicts  the 
original  CCD  camera  data.  The  second  row  shows  the 
same data after thresholding, such that low intensity points 
outside the cells are masked. The third row depicts the cal- 
culated data based on the single exponential fit through 
(all) original images. The accuracy of the fit can be esti- 
mated from a  comparison of the  second and third rows 
and with greater resolution in the fourth, which depicts the 
differences between the original and calculated data (mul- 
tiplied by 8). The fifth row shows the bleachable fraction 
of the initial fluorescence (Ampl image), the nonbleach- 
able  part  (Const.  image),  the  photobleaching time con- 
stant  image  %1  (Tau)  and  the  image  of its  relative  es- 
timated  S  E.  Also  included  are  a  histogram  of  the 
photobleaching time constants and a two dimensional his- 
togram of %1 vs the Ampl. image which shows the correla- 
tion between fluorescence intensity and  photobleaching 
kinetics. As can be seen from the very narrow distribution 
of %1, the bleach kinetics were very similar on different 
parts of the cells. For the FRET experiments, the standard 
output of the fitting program was modified to include a 
phase contrast image of the cells, the initial fluorescence 
image, the %1 image, the %1 temporal histogram, and the 
two-dimensional %1 vs Ampl. histograms (Figs. 3-5). The 
average statistics in Table I show a very large correlation 
coefficient, low residuals, and small standard deviations, 
attesting to the good quality of the experimental data. 
Effect of Temperature on EGFR Dimerization 
Determined by pb-FRET Microscopy 
In the pbFRET experiment depicted in Fig.  3, the pho- 
tobleaching times were compared for cells labeled with F1- 
EGF/native-EGF = 1:2, (donor in absence of acceptor, top 
images) with those of cells labeled with FI-EGF/Rh-EGF 
=  1:2 (donor in presence of acceptor, lower images). The 
incubation with EGF before fixation was for 40 min at 4°C 
and then for 5 min at 37°C. It can be clearly seen that the 
photobleaching time constants were higher for the cells la- 
beled with F1- and Rh-EGF than those for the cells labeled 
with  FI-  and  native-EGF.  This  difference  was  due  to 
FRET arising from receptor dimerization/oligomerization. 
Even though  the warming periods were very brief, it is 
likely that some internalization due to receptor-mediated 
endocytosis took  place,  particularly  at  37°C.  From  the 
quite homogeneous color (i.e., photobleaching rate) of the 
%1 images, however, it appears that the FRET efficiency 
was not correlated with certain cell structures. This homo- 
geneity can  also  be  inferred from the  narrow "rbl histo- 
grams and from the low average coefficients of variation 
(<CV>) of 7-8% for both labeling conditions (see Table 
I, in which other average image statistical parameters are 
also listed). From the average "rbt'S, we estimated an effec- 
tive transfer of 31%, a value consistent with a minimal re- 
ceptor dimerization of ~70% within the two compartment 
state model (Eq. 2). 
Similar experiments were performed at different tem- 
peratures. Fig. 4 shows the result of a 5-min warming to 
20°C after equilibrium binding at 4°C, whereas Fig. 5 de- 
picts the comparison data obtained without such a warm- 
ing period (control). The presence of FRET in Fig. 4 is ap- 
parent from the difference in the Tbj images. There was no 
obvious correlation between Tbl and cellular structures. In 
Fig. 5, however, the color in both Tbl images is nearly iden- 
tical implying a low FRET efficiency E. As can be inferred 
from the  various  average Tbl (see Table I),  the  average 
value of E  decreased with temperature (31,  14, and 4.6% 
at 37, 20, and 4°C, respectively). According to a two-com- 
The Journal of Cell Biology, Volume 129,  1995  1548 Figure 4. pbFRET microscopy of F1-EGF and Rh-EGF bound to A431 ceils after a 5-min exposure to room temperature.  Cells were la- 
beled as described in the legend to Fig. 3 but exposed to a warming period of 6 min at 20°C. Two sequences of 31 fluorescence micro- 
graphs were acquired by the CCD camera, with a shutter open time of 7.5 s. Two phase contrast images were also taken. Subsequent im- 
age analysis and processing was as described in Fig. 3. 
partment state (single and dimerized) receptor model (Eq. 
2),  the  minimal  average percentage of dimerization was 
69% at 37°C, 36% at room temperature, and only 13% at 
4°C. These results are indicative of a global, temperature- 
dependent dimerization process within 5 rain  after EGF 
binding to the receptor. 
EGF Dimerization Studied by FRET-FLIM 
The new technique  of fluorescence lifetime  imaging mi- 
croscopy (FLIM) directly determines the fluorescence life- 
times on single cells (21) and thereby is the most direct 
technique  available  to  quantitate  FRET in  cellular  sys- 
tems. The method has been described in detail elsewhere 
(21).  The standard output as described in that paper was 
modified in order to reproduce the two separate  experi- 
ments (H-fluorescence in the presence and absence of Rh) 
in  one figure.  The result  of such a  FLIM experiment is 
shown in Fig. 6. As expected, the fluorescence lifetime was 
reduced for the  double-labeled cells in comparison with 
single-labeled ones. This can be seen from the more bluish 
color in the x', image compared to the "r~ image and from 
the shift to the left of the ,r, distribution histogram. The 
same holds for -r  M. From the average -t,~, we determined a 
transfer efficiency of 16%  and from TM of 11%  (see also 
Table  I). These  values compare favorably with those  in 
Fig. 4.  The difference between  the  effective FRET effi- 
ciency determined  with  the  different  techniques  results 
from different weighing of the data (see discussion below). 
The distributions of x~ and XM are broader than the ones 
depicted in Fig. 4, due to the smaller number of sequence 
images taken and the lower statistical significance. 
Effect of mAb 2E9 on FRET Efficiency 
at Low Temperature 
To estimate the oligomerized state of the high affinity EGF 
receptors on A431 cells, photobleaching experiments were 
performed on cells preincubated with the monoclonal anti- 
body mAb 2E9. This antibody specifically blocks the sub- 
Gadella and Jovin Model  for Tyrosine Kinase Receptor Activation  1549 Figure 5.  pbFRET microscopy of FI-EGF and Rh-EGF bound to A431 cells after incubation at 4°C.  A431 cells were labeled as de- 
scribed in Fig. 3, however, the 5 min incubation at 37°C was canceled. Two sequences of 51 fluorescence micrographs were acquired by 
the CCD camera, the first image in both sequences with the excitation shutter closed (blank) and the others by opening the excitation 
shutter for 7.5 s each. Also two phase contrast images were acquired. Subsequent image analysis and processing was as described in the 
legend to Fig. 3. 
population of low affinity EGFR  (15). The results of this 
experiment are summarized in Fig. 7. The control incuba- 
tions showed a similar effect to that described in Fig. 5. Af- 
ter preincubation with mAb 2E9, the overall fluorescence 
labeling was clearly reduced (more than fivefold) reflecting 
the blocking of >80%  of the EGF-binding sites. Although 
the bleaching kinetics of FI-EGF (donor alone) were essen- 
tially unchanged, a large increase in %1 was observed in the 
double-labeling experiment. This result is in dramatic con- 
trast to that achieved in the control experiment without the 
mAb 2E9.  An average FRET  efficiency of 28%  was esti- 
mated,  corresponding  within  the  two-state  model  to  a 
---65% dimerization of the high affinity EGFR. In the re- 
gions of intercellular contact, "r'bl was lower (Fig. 7). These 
regions also exhibited a  relatively high fluorescence inten- 
sity.  We  infer  from  these  results  that  the  EGFR  in  the 
plasma membranes  involved in  cell-cell contact  was  less 
accessible to the mAb 2E9 antibody. A  transfer efficiency 
Figure 6.  FRET-FLIM of FI- and Rh-EGF bound to A431 cells after a 6-min exposure to room temperature. Cells were labeled as de- 
scribed in the legend to Fig. 4. For the FLIM measurement 20 phase images were acquired for each labeling condition at an HF of 39.19 
MHz (see Materials and Methods). These images were transferred to a MicroVax II system and analyzed by the SINUS program (20, 
21) and image processed with TCL-Image. The displayed image was generated by copying selected areas from the final TCL with the 
program NIH-Image (National Institutes of Health, Bethesda, MD). Text was added with Canvas (Deneba Software, Miami, FL). The 
The Journal  of Cell Biology,  Volume 129, 1995  1550 image consists of three columns. The first column depicts from top to bottom: an original phase image (left) and the corresponding ~ 
image (right) of cells labeled with F1-/Native-EGF =  1:2;  an original phase image plus corresponding ~'~ image of cells labeled with F1- 
Rh-EGF = 1:2; and similar images combining  the XM and x'M (lower two). The second column shows the temporal distribution  of the col- 
ored lifetime images in the first column, and the third column depicts the two-dimensional  histograms showing the correlation between 
the fluorescence intensity  (left half of the first column) and the fluorescence lifetimes (right half or  first column). 
Gadella and Jovin  Model  for Tyrosine  Kinase  Receptor  Activation  1551 Figure 7.  Effect of mAb 2E9 on the photobleaching kinetics of F1-EGF in the presence and absence of Rh-EGF, both bound to A431 
ceils. A431 cells were pretreated with (lower half images) or without (upper half images) 300 nM mAb 2E9 for 4 h at 4°C as described. 
Then 16.7 nM F1-EGF and either 33.3 nM native EGF (left half images) or 33.3 nM Rh-EGF (right half images) was added to the cells 
for 40 min at 4°C. Further image processing was as described above. 
(E) image (Fig. 8 A) was obtained by processing the lower 
right section of the TbZ image in Fig. 7 by use of Eq. 1. It is 
apparent from Fig. 8  that some regions exhibited a  much 
higher (and the intercellular regions a much lower) transfer 
efficiency than  the  average 28%.  By subsequent  applica- 
tion of Eq. 2, Fig. 8 A  was transformed into an etmi~ image 
(Fig. 8  B,  and as a  pseudo three-dimensional representa- 
tion  in  Fig.  8  C)  displaying the  minimal  percentage  of 
Figure 8.  Quantitation of FRET efficiency and minimal receptor dimerization of the high affinity EGF receptor subclass of A431 ceils 
labeled with F1- and Rh-EGF. By using <'rbt> = 43.32 S from the bleach experiment of F1-/Native-EGF =  1:2 in the presence of mAb 2E9 
(Fig. 7, bottom left images; Table I) the ~'blimage of the experiment with F1-EGF/Rh-EGF =  1:2 in the presence of mAb 2E9 (Fig. 7, bot- 
tom right images) was processed according to Eq. 1 to yield an E (transfer efficiency) image (A). By application of Eq. 2, this image was 
further processed to yield an a~in image (B). C is a pseudo-3D representation of B. 
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Fig. 8, B and C and within the context of a two-state mode, 
it is apparent that the (high affinity) population of EGFR 
resistant  to blockage by mAb 2E9 was  dimerized up to 
100%. 
Discussion 
In this study we investigated EGF receptor microcluster- 
ing on single cells by use of FRET-microscopy techniques. 
The application of FRET in previous studies of EGFR mi- 
croclustering was restricted to suspensions of intact cells 
or isolated plasma membranes (1, 8,  11) or to studies of 
the soluble, extracellular domain of EGFR (58). In these 
investigations, FRET was estimated from donor quench- 
ing (1, 8, 11) or sensitized acceptor emission (1). The ma- 
jor advantage of kinetic parameters (photobleaching time 
constants or fluorescence lifetimes), as opposed to steady- 
state  emission  signals,  is  that  they  are  independent  of 
labeling  efficiencies,  relative  affinities,  or  steady-state 
background  contributions  (28-30).  In  this  respect  it  is 
interesting to focus on the results described in references 
1,  8,  and  11.  Azevedo  and  Johnson  incubated  isolated 
plasma membranes with FI-EGF/Rh-EGF =  1:2; F1-EGF/ 
native-EGF  =  1:2; or native-EGF:Rh-EGF =  1:2. After 
incubation the unbound EGF was removed by pelleting 
the membranes and subsequent resuspension. The energy 
transfer was  estimated from comparison of the  fluores- 
cence emission spectrum of the membranes labeled with 
FI-EGF/Rh-EGF =  1:2 with that of a mixture of the other 
membranes. From the sensitized emission they estimated a 
transfer efficiency of 21%  at 37°C but in the same spec- 
trum,  donor  quenching  was  only 6%.  The  authors  ex- 
plained  the  discrepancy by slight changes  in  the  absor- 
bance spectrum of FI- and Rh-EGF after binding to the 
receptor, which can have a large effect on the calculation 
of sensitized emission. Although we did not observe differ- 
ences in the affinities of FI-, Rh-, and native-EGF for the 
receptor (Fig. 1), changes on the order of 5-10%  due to 
the introduction of the external probe cannot be excluded. 
Such differences would produce major errors (>100%) in 
the steady-state measurements of FRET described above. 
The alternative approach of Carraway and colleagues was 
to first label cells  (or membrane preparations)  with FI- 
EGF and then titrate with EGF labeled with eosin-isothio- 
cyanate (E-EGF) while monitoring the quenching of F1 
fluorescence. According to this approach FI-EGF would 
first occupy all the oligomerized (high affinity) sites, after 
which binding of E-EGF would be incapable of eliciting 
energy transfer. With intact cells, Carraway and colleagues 
indeed failed to find energy transfer with this method (8), 
whereas  with  isolated  membranes  they  detected  up  to 
20% energy transfer depending on the labeling conditions 
(8, 11).  In an effort to circumvent the problem posed by 
sequential additions, they added the labeled proteins si- 
multaneously but  obtained  essentially  the  same  results. 
We note that simultaneous addition poses two new prob- 
lems in such experiments: (1) there is no discrimination 
between bound and unbound EGF; and (2) any difference 
in relative affinities can introduce artifacts (see above). 
With time-resolved techniques, we were able to deter- 
mine FRET on single, attached, viable cells and demon- 
strated a temperature-dependent rapid microclustering of 
EGF receptors. The approach described here has the ad- 
vantage that no further control experiments need to be 
performed, inasmuch  as  the  difference in  F1-EGF pho- 
tobleaching kinetics or fluorescence lifetime can only be 
due to the presence or absence of Rh-EGF.  Changes in 
quantum yield or absorption coefficients upon binding of 
the  EGF-derivatives  to  the  receptor  are  irrelevant  for 
time-resolved determination of FRET since only the re- 
ceptor-bound fraction is monitored. Slight differences in 
affinity can proportionally change steady-state relative in- 
tensities but do not interfere with the determinations of 
photobleaching  kinetics  or  fluorescence  lifetime  of FI- 
EGF bound to receptor monomers, although they can of 
course influence the ratio of donor-to-acceptor labeling, 
causing it to deviate from the reagent ratio. The latter ef- 
fect would influence the FRET efficiencies but not the ac- 
curacy of their estimation. For the interpretation of the 
transfer efficiencies in terms of a lower limit for receptor 
dimerization a labeling ratio of 1:2 was assumed (fA =  2/3 
in Eq. 2). 
The low temperature incubation (4°C for 40 min, see 
Fig. 5) revealed donor photobleaching kinetics similar in 
the presence and absence of acceptor under control situa- 
tions. Such experiments rule out possible procedural arti- 
facts  like  fixation induced receptor clustering.  A  6-min 
warming period to room temperature after low tempera- 
ture binding of EGF caused a  substantial  increase in %1 
(Table I, Fig. 4), which was accompanied by a decrease in 
fluorescence lifetime (Table II, Fig. 6). Both parameters 
were indicative of energy transfer. Given the critical trans- 
fer distance Ro for FI-EGF to Rh-EGF FRET of 5.3 nm 
(1) energy transfer can only occur if the receptors are very 
close  together.  From  the  average  transfer  efficiency of 
31% after a 5-min warming period to 37°C, we could con- 
clude that the maximal distance between F1- and Rh-EGF 
in a  dimerized receptor is ~5  nm, assuming a  two state 
monomer/dimer model (unpublished data). In a dual cyl- 
inder  model  of the  EGF-receptor dimer,  with  an  EGF 
molecule bound in the center of each cylinder, this would 
imply  that  the  maximal  diameter/length  ratio  of  each 
EGFR monomer is N0.5  (assuming a molecular mass of 
170 kD and a density of 1.2 g/cm3). This ratio is indicative 
of an elongated receptor structure, allowing many contacts 
between the adjacent receptor monomers. 
EGF-induced dimerization of the  EGFR is  a  general 
phenomenon that has been described using a  variety of 
techniques  (see  also  introduction). With  purified recep- 
Table II. Mean Parameters from FLIM Experiments 
Acceptor*  x~  CV~  s.c.§  tauM  CV~  s.c.§  Ntl 
ns  %  ns  ns  %  ns 
no  3.3  27  0.8  4.6  19  0.8  3946 
yes  2.8  22  0.6  4.1  17  0.7  3738 
* Presence/absence of acceptor, no, incubation with F1-EGF/native-EGF =  1:2; yes, 
incubation with FI-EGF/Rh-EGF =  1:2. 
~: Coefficient of variation in ,r (100 ×  SD/mean, all pixels). 
§ Average standard error per individual x determination. 
cl Number of analyzed pixels (sine waves). In both cases the average correlation co- 
efficients  were  ~97%  and  the  average residuals  (=  ~[observed  -  calculated]2/ 
~observed  2) were ~3%. 
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nondenaturating gel electrophoresis and by density gradi- 
ent centrifugation (3, 56, 57). Studies on intact cells have 
been limited to spectroscopic or microscope-based tech- 
niques  using labeled  EGF.  In  addition  to FRET,  time- 
resolved phosphorescence  anisotropy  has  been  used  to 
monitor the microclustering of EGFR in cells and in mem- 
brane fragments (59-61). It was found that the rotational 
diffusion of receptor-bound EGF was slower at high tem- 
perature (37°C) than at low temperature (4°C), in agree- 
ment with our results.  Other nonmicroscope techniques 
applied to cells have made use of chemical cross-linkers in 
combination with  electrophoretic techniques  to  demon- 
strate the dimerized receptor. Despite the manifest utility 
of chemical cross-linking, it is accompanied by a number 
of pitfalls and artifacts (for an overview see reference 47). 
First, the method is highly specific in that hetero-associa- 
tions of EGFR with other proteins are scored (17). This 
effect will  be  even more  pronounced on permeabilized 
cells or on plasma membrane preparations. Second, some 
cross-linking  agents  can  diffuse  through  plasma  mem- 
branes of intact cells and hence cross-link already internal- 
ized receptors, such as those bound to elements of the cy- 
toskeleton (17). Third, the yield of cross-linking can never 
achieve 100%, leading to a systematic underestimation of 
the  fraction of dimerized receptor  (13).  Some  of these 
problems can be circumvented by appropriate control ex- 
periments, but we would rather emphasize the compara- 
tive virtues of the time-resolved fluorescence microscope 
techniques used in the present study: (a) they are highly 
sensitive and labeling is highly specific. (b) They produce 
spatial resolved information on single cells. (c) Perturba- 
tion of the system is minimal such that living cells can be 
studied (59). (d) The information obtained is very direct 
such that data interpretation is straightforward, allowing 
even a quantitative estimation of receptor dimerization. 
An intriguing and not yet completely resolved question 
concerns the oligomerized state of the high affinity recep- 
tor. Many studies have pointed to a linkage between high 
affinity  EGF  binding,  cellular  activation,  and  receptor 
dimerization (see Introduction). In some cases, the EGF 
concentration was varied in order to specifically label the 
high  affinity receptor. In  a  previous study it was  deter- 
mined that 12%  of the EGF receptors have high affinity 
sites (Kd =  0.7 nM) and 88% of the EGF receptors have 
low affinity sites (Kd =  36 nM) on A431 cells (59). High af- 
finity sites were selected by addition of only 3 nM EGF 
whereas the total population was selected by addition of 
110 nM EGF. In these two situations it can be shown that 
the ratio of high affinity to total binding would have been 
59%  and  15%,  respectively.  In  the  present  study  the 
monoclonal antibody 2E9 (15) was used to discriminate the 
high and low affinity receptors. This antibody essentially 
blocks low affinity EGF sites (15) and thereby provides a 
very specific tool for studying high affinity receptors. Inter- 
estingly, another monoclonal antibody has been described 
that specifically inhibits high affinity EGF-binding (2). Us- 
ing mAb 2E9, we could demonstrate a significant FRET ef- 
ficiency between FI- and Rh-EGF at 4°C, whereas in the 
absence  of the  antibody very low  efficiencies were  ob- 
tained (Fig. 7). At 4°C, EGF-receptor patch-formation and 
receptor-mediated endocytosis are completely inhibited (4, 
13, 22, 25, 40, 54), and hence the observed increase in trans- 
fer efficiency can only be explained in terms of microclus- 
tering or dimerization. Considering the substantial number 
of publications reporting on an EGF-receptor dimer (3, 13, 
17, 18, 40, 45, 46, 56-58), we interpret the observed transfer 
efficiencies in terms of receptor dimerization rather than 
generalized oligomerization. Applying a quantitative eval- 
uation based on a two-state model, we have concluded that 
receptor dimerization was close to 100% in some regions of 
A431  cells  treated  with  mAb  2E9  (Fig.  8).  This  result 
strongly suggests  that  the  high  affinity EGF receptor is 
present in a dimerized state. Since high affinity receptors 
can be activated by EGF (15) receptor dimerization per se 
may not necessarily lead to receptor activation. Rather, we 
favor the hypothesis of Spaargaren et al. (46) that the high 
affinity subclass consists of receptors in an intermediary in- 
active state which can be fully activated only upon EGF 
binding.  We  propose  a  model  in  which  both  receptor 
monomers undergo a relative rotation in response to the 
stereochemical interaction between two binding EGF mol- 
ecules (Fig. 9). This motion is transmitted to the cytoplas- 
mic domains of the two EGFR monomers, bringing them 
into a relative configuration favorable for activation of the 
tyrosine kinase (32). Such a "frozen" dynamic dimer model 
has been proposed for transmembrane signaling via recep- 
tors involved in bacterial chemotaxis (31). There are no al- 
losteric features in this 'twist' mechanism, inasmuch as a 
conformational transition  of the  macromolecular species 
influencing ligand-binding affinity is not required. It also 
provides the means for circumventing the difficulties en- 
countered in theoretical treatments of the binding-dimer- 
ization linkage paradigm (55). One can, for example, pos- 
tulate that the enhanced affinity of the EGFR dimer for 
the growth factor, a characteristic feature of the TKR sys- 
tems, arises from a hybrid-binding site comprising the pri- 
mary binding  locus  on  each monomer  and  a  secondary 
interaction site or sites on the second monomer. The pro- 
posed mechanism does not contradict the finding that the 
low  affinity (monomeric) receptors dimerize upon EGF 
binding. In addition, the low affinity receptors can be re- 
cruited after activation of the high affinity subpopulation, if 
one assumes that the potential for intermolecular phosphor- 
ylation and for progressive oligomerization (mediated con- 
ceivably via cytoskeletal interactions) exists in the EGFR 
population as a whole. For example, the reduced transla- 
tion (37) and rotational (59) mobilities of the high affinity 
EGFR are also evidenced in the total EGFR population af- 
ter exposure to 37°C  (37, 59,  61).  Likewise, the require- 
ment  for full-length receptor aggregation proposed in  a 
study of TKR activation by a  host of nonspecific factors 
(35)  can be  reformulated in  terms  of reorientations re- 
stricted to the  cytoplasmic domains  of the EGFR.  Con- 
versely, the TKR activation (38) or dimerization inhibition 
(58) capacity of mAbs binding to the external domain at 
sites other than that occupied by EGF, as well as the poten- 
tiating effect of introducing a covalent interreceptor link- 
age in the extracellular domain (45), can be explained in 
terms of either stabilization or destabilization/inhibition of 
the  active  stereochemical  structure  as  outlined  in  the 
scheme in Fig. 9. 
In conclusion, we have shown the temperature-depen- 
dent EGF-induced microclustering of the EGFR and have 
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formed EGFR dimers. Two unliganded monomers associate into 
a dimeric receptor with a preferential orientation. Ligand (EGF) 
binding leads to stereochemical exclusion and/or preferred orien- 
tation between the EGF ligands, requiring and accompanied by a 
mutual  rotation  (tw/st)  of the  two receptor monomers (all do- 
mains), and thereby leading to a corresponding reorientation and 
consequent  activation  of  the  tyrosine  kinase.  Conformational 
changes in the external domains  and/or the ligands are not re- 
quired, but one must assume a rigid relationship between the ex- 
tracellular  and  cytoplasmic domains  of the  EGFR  monomers. 
For further explanation, see Discussion. 
provided evidence for a dimerized state of the high affinity 
EGFR subclass on A431 cells. The proposed stereochemi- 
cal model provides an alternative for the allosteric activa- 
tion model proposed  by Ullrich  and  Schlessinger  (40,  50) 
in the sense that the functional state of the EGFR is a pre- 
formed but inactive dimer in the absence of EGF. We note 
by way of comparison that the covalently dimerized insu- 
lin receptor (homologous to an EGF receptor dimer) can 
be  activated  after  insulin  binding  (50).  Hence,  ligand- 
induced  intersubunit  interactions  in  the  extracellular  do- 
main  transduced  via  rigid  structures  to  intracellular  do- 
mains may be a general feature of the TKR family. 
Appendix: Calculation  of  Minimal Receptor 
Dimerization from Photobleaching  Curves 
Three  assumptions  are  made:  a  two-state  model:  the  re- 
ceptor is present  either  as a  monomer or as a  dimer; nei- 
ther  the  monomeric  nor  the  dimeric  receptor  forms  dis- 
criminate between donor and acceptor-labeled ligand (i.e., 
F1-EGF and Rh-EGF);  and an increase in photobleaching 
time only occurs when donor and acceptor-labeled ligands 
are present simultaneously on one receptor dimer. 
The fraction of donor ligand involved in energy transfer 
(fEZ) is given by 
fET  =  ira  et,  (A1) 
where et is the fraction of dimerized receptor and fa is the 
fraction of acceptor-labeled ligand. Suppose that in the ab- 
sence of acceptor (no energy transfer) energy transfer the 
photobleaching  time constant is I"  1 and in the presence  of 
acceptor potentiating energy transfer it is 7'1. Then the ac- 
tual decay curve is given by 
F (t)  =  rET~-~lexp/" --~-~1  )  +  (1  -- fET) exp  --  (12) 
In principle,  rl  and -r'  1 can be very close, so that a  double 
exponential  fit will lead  to errors.  For  this  reason  we  fit 
our data  to a  single  exponential  decay function  (see  also 
33) given by 
(')  Ffi  t(t)  =  aexp  -~  •  (A3) 
The  discrepancy  between  F(t)  and  Fnt(t)  is  minimized 
by defining  and  manipulating  the  difference  function 
V(a,Teff). 
2 
V(a,'reff)  =  I  {F(t)-Ffit(t)}  dt  (A4) 
t=0 
0V (a, 're  ff)  OV (a, "reff) 
V is minimized for  -  -  0. 
0a  0"ref  f 
By solving the  equations  for both  partial  derivatives,  lET 
can be expressed as a function of ~1, T'I and %ff. 
fET  =  ~'71 +  "reffJ  \  Teff _  "rl J 
(A5) 
In principle "/1 cannot be determined experimentally since 
100%  of the  receptors  must  be  dimerized,  and  100%  of 
these dimerized receptors must be labeled with donor and 
acceptor ligand  on either  site.  On  the  other hand,  ~1  and 
%~f can be determined  experimentally.  Eq.  15  can be re- 
written in terms of measured  (E)  and maximal (Emax) en- 
ergy transfer by defining 
0.8 
0.6 
0.4 
0.2 
,  i  , 
E~0.6 
E=0.4 
E=0.1 
I  I  I  i  I  i  I  a 
0.2  0.4  0.6  0.8 
E 
max 
Figure A  10.  Relationship between few, E  and Ema  x. 
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Teff 
"r 1 
Ema  x  =  1---"  (A7) 
,1"~ 1 
Substitution of A6 and A7 into Eq. A5 leads to 
-E-Ema  x)  [  E  -  Emax) 
In Fig. A10, fzv is plotted as a function of Em~x at several 
values of E. It is obvious that fET goes through a minimum. 
This observation is interesting as one can state that at a 
given value of E  (which can be  determined experimen- 
tally), fEX must be greater or equal to this minimal value. 
This value is found by setting the partial derivative of fET 
with respect to Ema~ to zero and solving for Em~, (Eq. A9). 
0fET  2 +  E 
0Ema  x  -  0  ~  (Emax)at  minimum =  ~  (A9) 
By substitution of this Ema  x value into Eq. A8, the minimal 
fraction fEV is obtained. 
8E 
-  (A10) 
(lET) minimum  (E +  2) 2 
Substitution of Eq. A1 into Eq. A10 leads to Eq. 2 in the 
text. 
Received for publication 8 November 1994 and in revised form 22 Febru- 
ary 1995. 
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